Could electric fields supercharge immune attack on the deadliest form of brain cancer?
LOS ANGELES — A new study led by Keck Medicine of USC researchers may have uncovered an effective combination therapy for glioblastoma, a brain tumor diagnosis with few available effective…
Read the full articleYou might also wanna read
Tumor-targeted interferon-α gene therapy for glioblastoma: a phase 1 trial
Phase 1/2a trial reports Temferon’s potential in GBM: 24 patients received stem cell transplants delivering INF-α2 to boost local antitumor
Non-lytic viral immunotherapy induces long-term glioblastoma survival and tumor-specific immunity without eliciting an antiviral response
A groundbreaking study unveils an RRV delivering IL-15 superagonist to glioblastoma, halting growth, extending survival, and boosting immune
Clinical trial explores high-dose vitamin B3 as potential treatment for glioblastoma brain cancer
A clinical trial is exploring whether high doses of vitamin B3 could give patients with glioblastoma a better chance against the aggressive
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
Conditions : Diffuse Intrinsic Pontine Glioma; DIPG; Brain Tumor; CNS Tumor; Central Nervous System Tumor; Pediatric Cancer; Adult Cancer Pa
Material damage to multielectrode arrays after electrolytic lesioning is insignificant
The quality of stable long-term recordings from chronically implanted electrode arrays is essential for experimental neuroscience and brain-
Personalized glioblastoma vaccine shows safety and survival promise in phase 1 trial
A new clinical trial has found that a personalized vaccine to treat glioblastoma is safe and could potentially improve outcomes.
futurity.org·1mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.